CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Ascendis Pharma to List Ordinary Shares Directly on Nasdaq

Positive
AI Analysis

Summary

Ascendis Pharma announced that its ordinary shares are expected to commence trading on Nasdaq on April 20, 2026, following the exchange of all American Depositary Shares.

Importance:4/10
Sentiment:
0.30
listingnasdaqshare_exchangecorporate_action
Related Companies

Read the original article

Published by GlobeNewswire Pharma on April 8, 2026 4:00 PM

Read Original